Safety and acceptability of 6% cellulose sulfate vaginal gel applied four times per day for 14 days

Contraception

Volumn 76, Issue 3, 2007, Pages 245-249

  Doh, Anderson S ^a   Ngoh, Nkele ^a   Roddy, Ron ^b   Lai, Jaim Jou ^c   Linton, Kim ^d   Mauck, Christine ^d  

^a Service de gynécologie et obstétrique Hôpital gynéco obstétrique et pédiatrique de Yaoundé   (Cameroon)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c FAMILY HEALTH INTERNATIONAL   (United States)

^d EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Acceptability; Cellulose sulfate; Colposcopy; Microbicide; Safety

Indexed keywords

CELLULOSE SULFATE; K Y JELLY; PETROLATUM; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANDIDIASIS; CELL DISRUPTION; CONTRACEPTION; CONTROLLED STUDY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GEL; GENITAL EPITHELIAL DISRUPTION; GENITAL LACERATION; GENITAL PAIN; GENITAL PRURITUS; GYNECOLOGIC DISEASE; HUMAN; PATIENT COMPLIANCE; RISK; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SIDE EFFECT; VAGINA BLEEDING; VAGINITIS;

ADULT; ANTI-INFECTIVE AGENTS, LOCAL; CANDIDIASIS, VULVOVAGINAL; CELLULOSE; EPITHELIUM; FEMALE; HUMANS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; SEXUALLY TRANSMITTED DISEASES; VAGINA; VAGINAL CREAMS, FOAMS, AND JELLIES; VAGINOSIS, BACTERIAL;

EID: 34547841571     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2007.05.083     Document Type: Article

References (15)

1. US Patent 6,063,773. 2000 May 16. Anderson RA, Zaneveld LJ, Usher TC, inventors; Polydex Pharmaceuticals, Ltd., Rush-Presbyterian-St. Luke's Medical Center, assignees. Cellulose sulfate for use as antimicrobial and contraceptive agent.
2. Astrup T., and Alkjaersig N. Polysaccharide polysulphuric acids as antihyaluronidases. Nature 166 (1950) 568-569
3. Cellulose sulfate investigator brochure, April 2007.
4. Mauck C., Weiner D.H., Ballagh S., et al. Single and multiple exposure tolerance study of cellulose sulfate gel: a phase I safety and colposcopy study. Contraception 64 (2001) 383-391
5. Schwartz J.L., Mauck C., Lai J.J., et al. Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety study. Contraception 74 2 (2006) 133-140 [Electronic publication 2006 May 2]
6. Malonza I.M., Mirembe F., Nakabiito C., et al. Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel. AIDS 19 (2005) 2157-2163
7. El-Sadr W., Mayer K., Maslankowski L., et al. Safety and acceptability of Cellulose sulfate as a vaginal microbicide in HIV-infected women. AIDS 20 12 (2006) 1109-1116
8. Personal communication from A. van der Straten.
9. Mauck C., Frezieres R., Walsh T., Robergeau K., and Callahan M. Cellulose sulfate: tolerance and acceptability of penile application. Contraception 64 (2001) 377-381
10. Jespers J., Buvé A., and Van Damme L. Safety trial of vaginal microbicide cellulose sulfate gel in HIV positive men. Sex Transm Dis 34 7 (2007) 519-522
11. Mauck C.K., Frezieres R., Walsh R., Peacock P., Schwartz J., and Callahan M.M. Noncomparative contraceptive effectiveness trial of cellulose sulfate gel. Obstet Gynecol 107 (2006) 14S
12. Raymond E.G., Chen P.L., and Luoto J. Spermicide Trial Group. Contraceptive effectiveness and safety of five nonoxynol-9 spermicides: a randomized trial. Obstet Gynecol 103 (2004) 430-439
13. World Health Organization and CONRAD manual for the standardization of colposcopy for the evaluation of vaginally administered products, Update 2000. Geneva and Arlington: WHO and CONRAD, 2000.
14. Agresti A., and Min Y. On small-sample confidence intervals for parameters in discrete distributions. Biometrics 57 (2001) 963-971 Cited in StatXact 5 User Manual, Cambridge, MA: Cytel, 2001.
15. FHI press releases dated August 28, 2006 and November 8, 2005. Available at http://www.fhi.org/en/AboutFHI/Media/Releases/index.htm.